Trial Profile
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms PCVFU
- 26 Oct 2020 Results of subanalysis assessing the mucosal IgA and IgG responses in PNG infants vaccinated with pneumococcal conjugate vaccine (PCV) followed by a pneumococcal polysaccharide vaccine (PPV) booster, published in the Vaccine
- 29 May 2012 Actual patient number changed from 450 to 280 according to ClinicalTrials.gov. (Follow-up trial: NCT01414504)
- 29 May 2012 Actual patient number changed from 450 to 280 according to ClinicalTrials.gov. (Follow-up trial: NCT01414504)